[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Tom Silver [@TomSilver39](/creator/twitter/TomSilver39) on x 9513 followers Created: 2025-07-14 23:50:18 UTC WF:" #Biotech Breaking the Billion: Predicting Blockbuster Trajectories For Drug Revenues: Spanning the nine therapeutic areas we analyzed, early revenue milestones—typically $100MM-$300MM/Q by Q4-Q10—strongly predict future blockbuster status. Hitting up to $250MM by Q7 was a consistent signal with an 86-100% probability of reaching $1B/year within 3-5 years of launch. For mega blockbusters, our analysis indicates reaching $750MM/Q by Q13 is a reliable predictor of achieving $5B/year within X years of launch; categorized blockbuster drugs by therapeutic area: Oncology (n=21) Immunology (n=11) Rare disease (n=10) Vaccines/Infectious disease (n=10) Metabolic disease (n=8) Neurology (n=4) Cardiovascular (n=2) Respiratory (n=1) Ophthalmology (n=1) ..."  XXXXX engagements  **Related Topics** [mega](/topic/mega) [$1byear](/topic/$1byear) [$250mm](/topic/$250mm) [$300mmq](/topic/$300mmq) [$100mm](/topic/$100mm) [Post Link](https://x.com/TomSilver39/status/1944907336965087698)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Tom Silver @TomSilver39 on x 9513 followers
Created: 2025-07-14 23:50:18 UTC
WF:" #Biotech Breaking the Billion: Predicting Blockbuster Trajectories For Drug Revenues: Spanning the nine therapeutic areas we analyzed, early revenue milestones—typically $100MM-$300MM/Q by Q4-Q10—strongly predict future blockbuster status. Hitting up to $250MM by Q7 was a consistent signal with an 86-100% probability of reaching $1B/year within 3-5 years of launch. For mega blockbusters, our analysis indicates reaching $750MM/Q by Q13 is a reliable predictor of achieving $5B/year within X years of launch; categorized blockbuster drugs by therapeutic area: Oncology (n=21) Immunology (n=11) Rare disease (n=10) Vaccines/Infectious disease (n=10) Metabolic disease (n=8) Neurology (n=4) Cardiovascular (n=2) Respiratory (n=1) Ophthalmology (n=1) ..."
XXXXX engagements
/post/tweet::1944907336965087698